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Pacific Islands: protocol for a before and after
intervention study
Jacqui Webster1*, Wendy Snowdon2,3, Marj Moodie4, Satu Viali5, Jimaima Schultz6, Colin Bell7, Mary-Anne Land1,
Shauna Downs1, Anthea Christoforou1, Elizabeth Dunford1, Federica Barzi1, Mark Woodward1 and Bruce Neal1,8Abstract
Background: There is broad consensus that diets high in salt are bad for health and that reducing salt intake is a
cost-effective strategy for preventing chronic diseases. The World Health Organization has been supporting the
development of salt reduction strategies in the Pacific Islands where salt intakes are thought to be high. However,
there are no accurate measures of salt intake in these countries. The aims of this project are to establish baseline
levels of salt intake in two Pacific Island countries, implement multi-pronged, cross-sectoral salt reduction programs
in both, and determine the effects and cost-effectiveness of the intervention strategies.
Methods/Design: Intervention effectiveness will be assessed from cross-sectional surveys before and after
population-based salt reduction interventions in Fiji and Samoa. Baseline surveys began in July 2012 and follow-up
surveys will be completed by July 2015 after a 2-year intervention period.
A three-stage stratified cluster random sampling strategy will be used for the population surveys, building on
existing government surveys in each country. Data on salt intake, salt levels in foods and sources of dietary salt
measured at baseline will be combined with an in-depth qualitative analysis of stakeholder views to develop and
implement targeted interventions to reduce salt intake.
Discussion: Salt reduction is a global priority and all Member States of the World Health Organization have
agreed on a target to reduce salt intake by 30% by 2025, as part of the global action plan to reduce the burden of
non-communicable diseases. The study described by this protocol will be the first to provide a robust assessment
of salt intake and the impact of salt reduction interventions in the Pacific Islands. As such, it will inform the
development of strategies for other Pacific Island countries and comparable low and middle-income settings
around the world.
Keywords: Salt, Sodium, Hypertension, Intervention, Surveillance, Diet, Food, Monitoring, Non-communicable
diseases, Pacific IslandsBackground
Non-communicable diseases (NCDs), including cardio-
vascular disease, cancer, diabetes and chronic respiratory
disease are the leading cause of death in the world, kill-
ing more people each year than all other causes com-
bined [1]. New Global Burden of Disease data indicate
that one in four deaths worldwide were due to ischemic* Correspondence: jwebster@georgeinstitute.org.au
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unless otherwise stated.heart disease or stroke in 2010 [2] and that blood pres-
sure is the most important global risk factor for health
[3]. In response, the United Nations has established a
target for all Member States to reduce NCD mortality by
25% by 2025 [4].
One of the main causes of high blood pressure is excess
dietary salt intake. Excess salt intake progressively elevates
blood pressure levels throughout life, which greatly in-
creases the risks of vascular diseases [5,6] and is likely to
be responsible for about half of the disease burden as-
cribed to high blood pressure [7]. Whilst there is stilll Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lar disease, the totality of the evidence is convincing
[8-10]. Much of the debate derives from the misinterpret-
ation of weak research [11]. Carefully conducted over-
views of the entirety of the evidence base consistently
draw the same conclusions about the significant adverse
effects of excess salt intake on health and the likely large
health gains that can be achieved from population-wide
salt reduction [12-14].
National and international organisations (including
the Australian National Health and Medical Research
Council [15], Health Canada [16], the American Heart As-
sociation [11], and the World Health Organization
[13,17]) advocate for programs that will reduce salt intake.
In addition, Member States at the World Health Assembly
in Geneva in May 2013 agreed on a global target to reduce
salt by 30% by 2025 [4].
The physiological requirement for salt is less than 1
gram per day [18] but, in populations where salt has
been measured, average daily intakes are between 9 and
12 grams [19]. Interventions to reduce salt have demon-
strated effectiveness in developed (high income) countries.
Japan and Finland both implemented successful salt re-
duction strategies in the 1970s [20,21] and the UK’s salt
reduction program, launched in 2003, has reduced aver-
age daily salt intake by about 1.5 grams (from 9.6 to 8.1
grams) in the last decade [22].
A recent review of salt reduction strategies in 32 coun-
tries [23] identified baseline data about salt intake levels
and patterns as a clear prerequisite for the successful de-
sign and implementation of effective interventions. Most
programs included work with the food industry to re-
duce the salt content of foods and meals, in parallel with
campaigns to change consumer behaviour [23-25]. Vol-
untary or mandatory initiatives to address labelling and
work to change the food environment through settings,
such as schools and hospitals, were also key elements of
many strategies.
Whilst there is a growing body of evidence about the
likely effectiveness of different strategies to reduce salt
intake, there are fewer data about their likely cost-
effectiveness; and a paucity of data on salt from low and
middle-income countries [26]. In Pacific Island countries,
an increased reliance on processed foods is contributing
to the rise in the incidence and prevalence of NCDs
[27-29]. Approximately 40% of all 9.7 million Pacific
Island citizens have been diagnosed with a NCD, mainly
cardiovascular disease or diabetes, and/or have hyperten-
sion [30].
Surveys in a number of Pacific Islands countries, using
the WHO STEP-wise approach to chronic disease risk fac-
tor surveillance (STEPS) [31], have confirmed high blood
pressure to be a significant NCD risk factor [32,33]. Salt in-
take is almost certainly a key contributor to this problemwith high sodium foods, such as bread, margarine, crack-
ers, noodles, canned foods, butter, soy and other sauces,
now staples for many households [28]. However, salt in-
take patterns have not been systematically and objectively
evaluated to date. While the limited available information
suggests high salt levels in many Pacific Island countries,
more detailed country specific information is required to
mount, and garner multi-sector support for, salt re-
duction programs [34]. For most countries it appears that
a population-wide salt reduction program would poten-
tially be one of the most cost-effective ways of improving
population health [35], but the evidence to drive con-
certed action is mostly absent [26].
This project, funded through the Global Alliance for
Chronic Disease (GACD) Hypertension Program, will help
to fill these gaps in the evidence. The Program is the first
initiative of its kind with the world’s largest funders of
medical and health research coming together to fund re-
search into non-communicable diseases (NCDs). Each of
the fifteen research projects are being conducted through
partnerships between investigators from institutions in
high-income and low-and middle-income countries. A key
focus of the program is implementation science and trans-
lation of evidence into policy and practice.
Methods/Design
The study will employ a before-after design. Baseline
(2012) and follow-up surveys (2015) will be conducted
either side of a multi-pronged, cross-sectoral interven-
tion that seeks to reduce population salt intake in Fiji
and Samoa over two years. The study will be conducted in
three phases and will use both quantitative and qualitative
research methods. Broadly, these three phases constitute:
– Phase I- Baseline assessments comprising population
surveys of salt intake, surveys of the salt content of
foods in shops, participatory community research to
understand stakeholder views, and an audit of
current practice.
– Phase II – Intervention development and
implementation using the baseline information to
formulate a comprehensive policy response and
action plan to reduce population salt intake.
– Phase III – Evaluation of impact through follow-up
community surveys, surveys of foods in shops
and a cost-effectiveness analysis.
Study objectives
The overall study objective is to assess the effect of a
multi-pronged, cross-sectoral intervention program to
reduce population salt intake in both Fiji and Samoa.
Secondary objectives include determining the effects of
the salt reduction program on population knowledge, at-
titudes and behaviour by comparing mean population
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fects of the salt reduction program on average levels of
sodium in foods based upon food composition surveys
that collect data from food labels at baseline and follow-
up. The project will also consider the effects of the salt re-
duction intervention on dietary salt by examining changes
in diet based on the Food Frequency Questionnaires
(FFQs) administered at baseline and follow-up in each
country. The relationship between salt intake measured by
24-hour urine and salt intake estimated from spot urine
will also be explored.
Outcomes
Primary
The primary outcome of the study will be the change
in 24-hour urinary salt level in the overall study popula-
tion (in each country). If a positive impact is demon-
strated, then a cost-effectiveness assessment will also be
undertaken.
Secondary outcomes
The main secondary outcomes will be changes in know-
ledge levels and current practices relating to salt and
changes in the mean concentration of sodium in foods.
Additional outcomes will include changes in the com-
position of diet based on the FFQs and understanding of
the relationship between salt intake measured by spot
and 24-hour urine in each country. The latter is import-
ant as, if it proves possible to use spot urines to estimate
24-hour urinary sodium excretion, in future this would
provide a more feasible and practical alternative to meas-
uring salt intake for countries.
Sampling strategy
The study population will be adults aged 18–69 years in
both countries. Baseline salt assessment and questions
on knowledge, attitudes and behaviours related to salt
(KAB) will be integrated into the WHO STEPS survey in
Samoa and the STEPS sampling framework will be used
in Fiji. The framework uses a stratified (province or div-
ision) three-stage (enumeration area, household and indi-
vidual) cluster random sampling process using probability
proportional to size to obtain representative samples for
the STEPS survey in each country based on the statistical
regions identified in recent Censuses [36-38]. Sub-samples
(e.g. every fifth person, so as to recruit 250 men and 250
women) will then be selected to collect 24-hour and spot
urines.
Recruitment
Before beginning recruitment, permission will be sought
from the local village chief to enter the village or enu-
meration area to carry out the work. Study enrolment
and data collection will be conducted face-to-face inEnglish (which is spoken by more than 90% of people
in Fiji and Samoa) by trained health research staff.
The research assistants will assist participants by or-
ally translating written material into the local language, if
needed. Participant information sheets and consent
forms will be available in Hindi and Fijian (for Fiji) and
Samoan. Each consented participant will be assigned a
unique identification number so that survey results can
be kept separate from personal details to ensure data
confidentiality.
Data collection and management
Interviewer administered questionnaires will be used to
obtain demographic and risk factor related information,
including knowledge, awareness and practices related to
salt from all participants. In addition, dietary intake will
be assessed by trained research assistants using food fre-
quency questionnaires (FFQs) on the sub-sample. The
FFQ has been previously used to measure population
salt intake in Fiji [39]. It will be adapted for Samoa, in-
formed by the list of foods collected during the STEPS
survey. Spot and 24-hour urine samples will be collected
for each participant in both countries in accordance with
established protocols [40]. All methods will be piloted as
part of the training processes in each country.
Sample size
The sample size for each survey has been calculated to
provide precise estimates of the average level of salt separ-
ately in adult Samoans and Fijians, based on the 24-hour
urine collections. Five hundred participants recruited in
both Fiji and Samoa will allow reporting of the mean level
of sodium intake to within +/− 4.2 mmol with 95% confi-
dence for each country. This estimate assumes a mean
intake of 160 mmol sodium per day with a standard devi-
ation of 48 mmol (1 gram of salt = 17.1 mmol sodium).
This sample size will also enable the mean level of sodium
to be reported to within +/− 5.85 mmol, for men and
women and for rural and urban areas (where the sample
is effectively divided in two with a sample size of 250 in
each group), and to within +/− 8.42 mmol for subgroups
such as older vs. younger men or rural versus urban
women (where there will be a sample size of about 125 for
each group). There will also be 80% power (alpha = 0.05)
to detect approximately 8.5 mmol (0.5 gram salt) or greater
differences between the average sodium levels between
baseline and follow-up for each country.
Analysis methods
The spot and the 24-hour urine samples from each indi-
vidual will be analysed separately for sodium, potassium
and creatinine. All analyses will be done by local labora-
tories in Samoa and Fiji using the ion selective elec-
trode method for sodium and potassium analysis and
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for urine creatinine assay. Age and sex specific estimates
obtained from the survey will be weighted based on popu-
lation data from the most recent census. Descriptive sta-
tistics will be reported for anthropometrics, consumer
awareness and urinary sodium levels. Results will be re-
ported by sex age groups and evidence for differences be-
tween subgroups examined using t-tests.
Surveys of the salt content of foods for sale in shops
Sampling strategy
The salt levels in the foods that contribute most to salt
in the diet (identified through the FFQs) will be moni-
tored according to published protocols [41] with the lar-
gest stores in the main urban centres of Fiji (Suva) and
Samoa (Apia) included in the surveys. Additional chem-
ical analysis of the sodium content of the main meals
eaten in and out of the home will be undertaken by na-
tional government laboratories in each country.
Data collection and management
The food composition data will be collected primarily
from printed information on the front and back of the
product labels, including the nutrition information panel.
The minimum data fields collected for each product will
be country of origin, brand/manufacturer, product name,
food category, serving size and sodium content per 100 g
and/or per serving. Direct chemical analysis of the sodium
content of a sub-sample of products will be undertaken to
assess the accuracy of the sodium content listed on the
nutrition labels. Direct chemical analysis will also be used
to obtain sodium content data for products and meals that
have been identified through the FFQ as contributing sig-
nificantly to salt in the diet and that are unpackaged or do
not display a nutrient declaration.
Analysis methods
The primary analysis will compare the mean concentra-
tion of sodium in foods before and after the salt reduc-
tion intervention has been implemented. Subsidiary
analyses will explore changes in sodium levels in differ-
ent food types and for the foods marketed by different
manufacturers.
Development of the salt reduction program
The development of the salt reduction program will be
under-pinned by participatory community research [42]
to obtain a comprehensive understanding of consumer
and stakeholder opinions in relation to the most effect-
ive mechanisms for reducing salt intake. Stakeholder
consultation will be conducted in both Fiji and Samoa
and, while it is anticipated to be considerable overlap in
the findings, the different structural social and cultural
factors in each country will be carefully considered.Participatory community research
Focus groups of up to two hours’ duration will be held
with key stakeholders using a trained local professional
research person and a semi-structured interview ques-
tion format. The sessions will focus on assessment of po-
tential barriers and opportunities for change in relation
to reducing salt intake or salt levels in foods, and the likely
impact, feasibility and acceptability of different possible
interventions.
Representatives of the food industry (manufacturers,
importers, caterers, ingredients suppliers), government
(Ministries of Health, Transport, Commerce and Industry,
Finance and Women and Culture), consumers, NGOs and
Church Groups and international organisations, will be in-
vited to participate in approximately 10 focus groups (of
8–10 participants ) in each country, allowing for a broad
range of opinion. Purposive snowball sampling [43] will be
used to identify stakeholders in each country with existing
organisations, such as women’s groups and church groups,
used to identify additional potential participants. Separate
focus groups will be conducted for stakeholders from dif-
ferent sectors (government, industry, community). The
assessment of the potential interventions will be guided
by background information about existing national and
regional commitments, and relevant evidence on policy
options. The focus group sessions will be recorded and
subsequently transcribed verbatim.
Focus group transcripts will be coded and organized
according to key themes with analysis that seeks to
elucidate barriers and opportunities for change and the
feasibility and acceptability of different interventions. The
findings will be explored overall and separately for the
consumer, government and industry groups. At the com-
pletion of the analysis, the possible interventions will be
ranked on the basis of potential impact, feasibility and ac-
ceptability. The key secondary analysis will be a detailed
assessment of the main barriers and opportunities for
change.
Salt reduction intervention
While the nature of the salt reduction intervention strat-
egies will be informed by the outcome of the stakeholder
consultation and other baseline data collected during the
project, it is likely that the program will include core
components and approaches employed elsewhere. In
addition, the strategies will reinforce existing national
programs being implemented by the Ministry of Health
and key agencies in each country. Core components of
the programs will include: (i) the food industry (includ-
ing caterers, bakers, importers, processors and retailers)
with efforts directed towards reducing average salt levels
in locally manufactured and imported foods towards
agreed targets for salt levels in foods, work to facilitate
the catering and food service sectors to provide low salt
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stores and food service outlets; (ii) consumers through
targeted and sustained campaigns to change awareness
and behaviours related to salt with a focus on children
and using culturally appropriate communication chan-
nels including church leaders and women’s groups; and
(iii) settings such as schools, hospitals and the workplace
through the establishment of standards and educational
campaigns.
Cost-effectiveness analysis
Incremental cost-effectiveness analysis will be under-
taken to determine whether the intervention strategy
in each country represents ‘value-for-money’ measured
against current practice. It will address issues of both
technical efficiency (‘how to do it’) through assessment of
key design features of the intervention strategy and the as-
sociated cost drivers, and allocative efficiency (‘what to
do’) through the modelling of longer term consequences
and cost offsets. The analyses will be conducted from a so-
cietal perspective for the 2013 reference year. Pathway
analysis (‘who does what to whom, when and where and
how often’) will be used to specify resources associated
with the interventions. Detailed documentation of all ac-
tivities undertaken, and their associated resource costs,
will be conducted throughout the study duration to facili-
tate comprehensive costing of interventions (excluding
and including measurements).
Economic modelling will be used to extend the target
population, time horizon and decision context for the
cost-effectiveness analysis. The incremental change in
salt consumption, as a result of the intervention strategy,
will be converted to savings in Disability-Adjusted Life
Years (DALY) over the lifetime of the national cohort
(Fiji and Samoa separately), with the resulting incremen-
tal cost-effectiveness ratios expressed as cost per DALY
saved. Standard discounting will be applied to both costs
and outcomes. Simulation-modelling using the @RISK
software package will be employed to calculate 95% un-
certainty intervals (around the median) about the effi-
cacy and cost estimates.
Ethics and dissemination
Ethics approval for this study has been obtained from
the Human Research Ethics Committee at the University
of Sydney and Deakin University in Australia and from
the local ethics committees in Fiji (Fiji National Ethics
Review Committee) and Samoa (Ministry of Health).
Results will be presented and made available to MOH
staff in each country, published in a high quality peer-
reviewed journal and disseminated widely through con-
ferences and events, using the George Institute, C-POND
and Global Alliance for Chronic Disease stakeholder
networks.Discussion
The potential for salt reduction to reduce the burden of
NCDs has now been endorsed internationally [44], with
projections in recent studies that interventions would
save millions of lives a year and be cost-saving to gov-
ernments in the long run [35,45]. Samoa and Fiji both
have relatively strong approaches to NCD prevention
and have already highlighted salt reduction as a priority.
Existing data on salt intake from Pacific Island countries
are, however, sparse and this study will directly benefit
Fiji and Samoa and be a major step forward in enabling
the development and implementation of local salt reduc-
tion programs [46]. Both countries have identified the
need for accurate information on current salt intake and
sources of sodium in the diet to inform their plans for
interventions. As such, there is a high likelihood that
this project will translate into practical interventions
with the potential to save lives and avert disease burden
in the short term.
Key strengths include important new scientific data
and capacity building in relation to monitoring and
surveillance, intervention implementation and cost-
effectiveness evaluation of salt reduction interventions
in Fiji and Samoa. The project will use the gold standard
method of 24-hour urine collection to monitor salt intake.
Integrating the monitoring into the WHO STEPS pro-
gram will ensure the collection of high quality data on a
representative population sample and be crucial in ensur-
ing the future sustainability of the salt monitoring as it is
recommended that STEPs NCD risk factor surveys are
repeated every five years. The participatory nature of the
approach involving a diverse range of stakeholders will re-
sult in important contextual information which should
improve the effectiveness of the intervention strategies.
In both countries, the project will involve government
throughout the process of developing and implement-
ing policiesx and interventions, which should facilitate
knowledge translation and ensure that salt reduction
remains on the government agenda. The sample size
will ensure adequate power to detect a small but clin-
ically significant change in salt intake over a relatively
short period.
The study has a before and after design with no con-
trol group. However, whilst randomised control trials are
the gold standard, it is not always possible to replicate
them in real life settings and so the design described here
is more appropriate. Differences in terms of governance
(principal research staff employed in research organisation
in Fiji and in the Government Health Department in
Samoa), and interventions (building on the on-going strat-
egy in Fiji and developing a new strategy in Samoa) will
also need to be taken into account when considering the
effectiveness and constitute a key strength of the study.
Process evaluations will enable us to make judgements
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and help to identify the more feasible and practical ap-
proaches for salt reduction, particularly for low and
middle-income countries with limited resources. Import-
ant new evidence on the appropriateness of spot urines to
estimate 24-hour urinary sodium excretion in the Pacific
Islands will be another key outcome of the study. All of
these findings will be used to inform WHO guidance
around sodium currently being developed and as such will
have an immediate impact on international policy and
practice. This will increase the potential for all countries
to achieve the new global targets for salt reduction and as
such have a major impact on NCDs around the world.
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